Featured HeartMate II and 3 LVADs Recalled Due to Potential for Outflow Graft Obstruction Initiated by Abbott/Thoratec and deemed Class I by the FDA, the recall is a response to reports of 273 injuries and 14 deaths. By Caitlin E. Cox April 22, 2024